Lionshead Wealth Management, LLC

Position in PFE — Pfizer Inc

CIK 2056752 New York, NY

Position in PFE

as of Jun 30, 2026 · filed Jul 28, 2026 Compact

Position Value

$702,461

-$119,328 QoQ

Shares Held

29,172

-0.3% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

1.25%

of 13F equity value

Holder Rank

#1,530

of 2,821 holders

Holding Since

Dec 2024

7 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Lionshead Wealth Management, LLC holds $4,038,187 across 5 Drug Manufacturers - General names. PFE ranks #4 (17.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc.	4,720	$1,187,740
2	LLY	ELI LILLY & Co	969	$1,162,247
3	MRK	Merck & Co., Inc.	5,754	$739,389
4	PFE	Pfizer Inc This page	29,172	$702,461
5	JNJ	Johnson & Johnson	970	$246,350

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$702,461	29,172	-0.3%	Shares	Sole	2026-07-28
2026-03-31	$821,789	29,266	+0.1%	Shares	Sole	2026-05-11
2025-12-31	$727,926	29,234	+0.1%	Shares	Sole	2026-01-13
2025-09-30	$743,990	29,199	+17.3%	Shares	Sole	2025-10-10
2025-06-30	$603,648	24,903	+0.9%	Shares	Sole	2025-08-12
2025-03-31	$625,492	24,684	-8.6%	Shares	Sole	2025-05-14
2024-12-31	$716,416	27,004	—	Shares	Sole	2025-02-14
No filing history on record for this holder in this stock.